This program training proposal renewal is designed to train urologic surgeons and PhD scientists in basic science research relevant to urology. We propose to train four T32 positions/year over five years renewal period in applied basic research relating to relevant urologic diseases. Our primary goal is to help these bright young scientists bridge the transition from supervised research training to careers as independent investigators addressing important questions in urology. We have been highly successful since 1998 in the combined K12/T32 training programs. We trained four physician scientists and four PhD postdocs. The overall research focus of the trainees is the molecular biology of neuro-epithelial function, cancer and inflammation. The faculty is highly qualified, and all the mentors have extramural research support and much training experience. Upon completion of the training program the fellow will understand how to design, carry out, and complete experiments to answer discrete biological questions. The fellow will thus be trained, not simply in the sophisticated laboratory methodology of molecular biology, biochemistry, immunology, and cell biology, but also in the thought processes to apply to future experimental programs. All trainees will have the opportunity to take formal academic courses offered by the basic science departments of the University of Pittsburgh. All training will take place in the laboratories of the principal mentors who are all extramural grant-funded senior scientists using a carefully thought-out and well-proven modification of the master/apprentice system. The central training technique combines weekly one-on-one meetings between the apprentice and the mentor plus twice weekly, hour-long research training seminars with supervising subcommittees consisting of four or five mentors. The subcommittee members will possess the special skills to supplement the principal mentor's skills, and concurrently monitor and guide the trainees' research program. This intense supervision permits efficient, friendly, and collaborative research and training simultaneously. The individual fellows choose a principal mentor and the Executive Training Committee will tailor a fellowship supervising committee of faculty co-mentors to provide expert training necessary to supplement the talents of the principal mentor. Affirmative action recruitment will be an integral component of recruitment and selection process. The training facilities can serve more fellows than will be funded by this training proposal. All the training can be carried out in the more than 55,000 square feet of fully equipped laboratory space available.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Moen, Laura K
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pittsburgh
Schools of Medicine
United States
Zip Code
Pascal, Laura E; Wang, Yao; Zhong, Mingming et al. (2018) EAF2 and p53 Co-Regulate STAT3 Activation in Prostate Cancer. Neoplasia 20:351-363
Zang, Yachen; Pascal, Laura E; Zhou, Yibin et al. (2018) ELL2 regulates DNA non-homologous end joining (NHEJ) repair in prostate cancer cells. Cancer Lett 415:198-207
Ai, J; Pascal, L E; Wei, L et al. (2017) EAF2 regulates DNA repair through Ku70/Ku80 in the prostate. Oncogene 36:2054-2065
Pascal, Laura E; Masoodi, Khalid Z; Liu, June et al. (2017) Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasia. J Endocrinol 235:123-136
Qiu, Xiaonan; Pascal, Laura E; Song, Qiong et al. (2017) Physical and Functional Interactions between ELL2 and RB in the Suppression of Prostate Cancer Cell Proliferation, Migration, and Invasion. Neoplasia 19:207-215
Wang, Yao; Pascal, Laura E; Zhong, Mingming et al. (2017) Combined Loss of EAF2 and p53 Induces Prostate Carcinogenesis in Male Mice. Endocrinology 158:4189-4205
Liu, Teresa T; Grubisha, Melanie J; Frahm, Krystle A et al. (2016) Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor ? (ER?) Response to 5?-Reductase Inhibition in Prostate Epithelial Cells. J Biol Chem 291:14747-60
Gurski, Lisa A; Knowles, Lynn M; Basse, Per H et al. (2015) Relocation of CLIC1 promotes tumor cell invasion and colonization of fibrin. Mol Cancer Res 13:273-80
Eisermann, Kurtis; Dar, Javid A; Dong, Jun et al. (2015) Poly (A) Binding Protein Cytoplasmic 1 Is a Novel Co-Regulator of the Androgen Receptor. PLoS One 10:e0128495
O'Malley, Katherine J; Eisermann, Kurtis; Pascal, Laura E et al. (2014) Proteomic analysis of patient tissue reveals PSA protein in the stroma of benign prostatic hyperplasia. Prostate 74:892-900

Showing the most recent 10 out of 27 publications